Onconetix, Inc. Defined Benefit Plan, Plan Assets, Benefits Paid
Onconetix, Inc. (ONCO) reported Defined Benefit Plan, Plan Assets, Benefits Paid of $10.53 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid · last filed 2026-03-13
- Onconetix, Inc. defined benefit plan, plan assets, benefits paid for the quarter ending 2025-06-30 was $4.74K.
- Onconetix, Inc. defined benefit plan, plan assets, benefits paid for the quarter ending 2025-03-31 was $4.80K.
- Onconetix, Inc. defined benefit plan, plan assets, benefits paid for fiscal 2025 was $10.53K, a 49.43% decline from fiscal 2024.
- Onconetix, Inc. defined benefit plan, plan assets, benefits paid for fiscal 2024 was $20.82K.
| Period end | Defined Benefit Plan, Plan Assets, Benefits Paid 3 month | Defined Benefit Plan, Plan Assets, Benefits Paid 6 month | Defined Benefit Plan, Plan Assets, Benefits Paid 12 month |
|---|---|---|---|
| 2025-12-31 | $10.53K 10-K · filed 2026-03-13 | ||
| 2025-06-30 | $4.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.54K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.80K 10-Q · filed 2025-06-12 | ||
| 2024-12-31 | $20.82K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |